van Dalfsen JH, Markus CR
Key takeaways Ozempic, like all GLP-1s, carries a black box warning on its label due to a possible association between their use and thyroid C-cell tumors, a rare thyroid cancer
Feltman: Yeah, and GLP-1 is a peptide, right
The appetite decrease is of course part of the intended mechanism, but it can become excessive during aggressive titration, leading to inadequate caloric and protein intake
Pricing Pressure Accelerates Adoption At $149/month self-pay for the starter dose, oral GLP-1s enter the market at a materially more accessible price point than injectable WEGOVY (which retails at $1,349/month before discounts)